Literature DB >> 7258180

Late relapses in Hodgkin disease.

J R Kanofsky, H M Golomb, J E Vardiman, D L Sweet, J E Ultmann.   

Abstract

Among a cohort of 142 patients with Hodgkin disease (HD), pathologic stages (PS) IA through IVB, 84 remained in complete remission (CR) at least 3 years after the completion of initial protocol therapy. Eight of these patients subsequently developed a recurrence of HD and were defined as having a late relapse. The disease-free interval ranged from 37 to 76 months (median 53 months). Six of the relapse patterns were those of dissemination. All patients were salvaged and are in CR from 14 to 50 months after relapse. The actuarial survival, measured from the time of relapse, of the eight late-relapsing patients was superior to the actuarial survival of 38 patients with early relapse (disease-free interval less than 36 months), but as yet this difference is not statistically significant (P = 0.07, Gehan).

Entities:  

Mesh:

Year:  1981        PMID: 7258180     DOI: 10.1002/ajh.2830100106

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

Authors:  Francesco Gaudio; Annamaria Giordano; Vincenzo Pavone; Tommasina Perrone; Paola Curci; Domenico Pastore; Mario Delia; Clara De' Risi; Alessandro Spina; Vincenzo Liso; Giorgina Specchia
Journal:  Adv Hematol       Date:  2010-12-29

Review 2.  Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry.

Authors:  Maja Dam Andersen; Stephen Hamilton-Dutoit; Lena Modvig; Maja Vase; Ilse Christiansen; Jacob Haaber Christensen; Rasmus Bo Dahl-Sørensen; Danny Stoltenberg; Peter Kamper; Francesco d'Amore
Journal:  Br J Haematol       Date:  2022-04-08       Impact factor: 8.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.